TrialJapanese journal of ophthalmology2021

An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet's disease in long-term remission.

Yasutsugu Ida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.